P2Y receptors as regulators of lung endothelial barrier integrity
Abstract
Endothelial cells (ECs), forming a semi-permeable barrier between the interior space of blood vessels and underlying tissues, control such diverse processes as vascular tone, homeostasis, adhesion of platelets, and leukocytes to the vascular wall and permeability of vascular wall for cells and fluids. Mechanisms which govern the highly clinically relevant process of increased EC permeability are under intense investigation. It is well known that loss of this barrier (permeability increase) results in tissue inflammation, the hall mark of inflammatory diseases such as acute lung injury and its severe form, acute respiratory distress syndrome. Little is known about processes which determine the endothelial barrier enhancement or protection against permeability increase. It is now well accepted that extracellular purines and pyrimidines are promising and physiologically relevant barrier-protective agents and their effects are mediated by interaction with cell surface P2Y receptors which belong to the superfamily of G-protein-coupled receptors. The therapeutic potential of P2Y receptors is rapidly expanding field in pharmacology and some selective agonists became recently available. Here, we present an overview of recently identified P2Y receptor agonists that enhance the pulmonary endothelial barrier and inhibit and/or reverse endothelial barrier disruption.Citation
J Cardiovasc Dis Res. 2011 Jan-Mar; 2(1):14-22ae974a485f413a2113503eed53cd6c53
10.4103/0975-3583.78582
Scopus Count
Related articles
- Cytoskeletal mechanisms regulating vascular endothelial barrier function in response to acute lung injury.
- Authors: Kása A, Csortos C, Verin AD
- Issue date: 2015
- Prolyl Hydroxylase Domain-2 Protein Regulates Lipopolysaccharide-Induced Vascular Inflammation.
- Authors: Fan Q, Mao H, Xie L, Pi X
- Issue date: 2019 Jan
- Protective effect of purinergic agonist ATPgammaS against acute lung injury.
- Authors: Kolosova IA, Mirzapoiazova T, Moreno-Vinasco L, Sammani S, Garcia JG, Verin AD
- Issue date: 2008 Feb
- Agonists for Bitter Taste Receptors T2R10 and T2R38 Attenuate LPS-Induced Permeability of the Pulmonary Endothelium in vitro.
- Authors: Kertesz Z, Harrington EO, Braza J, Guarino BD, Chichger H
- Issue date: 2022
- Molecular mechanisms in lipopolysaccharide-induced pulmonary endothelial barrier dysfunction.
- Authors: Liu H, Yu X, Yu S, Kou J
- Issue date: 2015 Dec